COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,973 Articles (22,604 medRxiv, 8,369 bioRxiv)

Most recent first Previous |  Page 1685: Articles 16841-16850  | Next

Is there a serum proteome signature to predict mortality in severe COVID-19 patients?
Voellmy, F., van den Toorn, H., Zenezini Chiozzi, R., Zucchetti, O., Papi, A., Volta, C. A., Marracino, L., Vieceli Dalla Sega, F., Fortini, F., Campo, G., Contoli, M., Spadaro, S., Rizzo, P., Heck, A. J. R.
10.1101/2021.03.13.21253510 — Posted: 2021-03-13
Diurnal variation in SARS-CoV-2 PCR test results: Test accuracy may vary by time of day
McNaughton, C. D., Adams, N. M., Johnson, C. H., Ward, M. J., Lasko, T. A.
10.1101/2021.03.12.21253015 — Posted: 2021-03-13
Seroprevalence of Antibodies to SARS-CoV-2 among Health Care Workers in Kenya
Etyang, A. O., Lucinde, R., Karanja, H., Kalu, C., Mugo, D., Nyagwange, J., Gitonga, J., Tuju, J., Wanjiku, P., Karani, A., Mutua, S., Maroko, H., Nzomo, E., Maitha, E., Kamuri, E., Kaugiria, T., Weru, J., Ochola, L. B., Kilimo, N., Charo, S., Emukule, N., Moracha, W., Mukabi, D., Okuku, R., Ogutu, M., Angujo, B., Otiende, M., Bottomley, C., Otieno, E., Ndwiga, L., Nyaguara, A., Voller, S., Agoti, C., Nokes, D. J., Ochola-Oyier, L. I., Aman, R., Amoth, P., Mwangangi, M., Kasera, K., Nganga, W., Adetifa, I., Kagucia, W., Gallagher, K., Uyoga, S., Tsofa, B., Barasa, E., Bejon, P., Scott, J. A. G., Agweyu, A., Warimwe, G.
10.1101/2021.03.12.21253493 — Posted: 2021-03-13 Discussion: Onsite
Limits of lockdown: characterising essential contacts during strict physical distancing
Thomas, A. C., Danon, L., Christensen, H., Northstone, K., Smith, D., Nixon, E. J., Trickey, A., Hemani, G., Sauchelli, S., Finn, A., Timpson, N. J., Brooks-Pollock, E.
10.1101/2021.03.12.21253484 — Posted: 2021-03-13
COVID-19 Risk Factors and Mortality among Native Americans
Leggat-Barr, K., Uchikoshi, F., Goldman, N.
10.1101/2021.03.13.21253515 — Posted: 2021-03-13 Discussion: Onsite | Offsite
Multi-resolution characterization of the COVID-19 pandemic: A unified framework and open-source tool
Shi, A., Gaynor, S. M., Quick, C., Lin, X.
10.1101/2021.03.12.21253496 — Posted: 2021-03-13
Persistence of SARS-CoV-2 virus and viral RNA on hydrophobic and hydrophilic surfaces and investigating contamination concentration
Paton, S. E., Spencer, A., Garratt, I., Thompson, K.-A., Dinesh, I., AranegaBou, P., Stevenson, D., Clark, S. O., Dunning, J., Bennett, A. M., Pottage, T.
10.1101/2021.03.11.435056 — Posted: 2021-03-13
A potential SARS-CoV-2 variant of interest (VOI) harboring mutation E484K in the Spike protein was identified within lineage B.1.1.33 circulating in Brazil
Resende, P. C., Graf, T., Paixao, A. C. D., Appolinario, L., Lopes, R. S., Mendonca, A. C. F., da Rocha, A. S. B., Motta, F. C., Neto, L. G. L., Khouri, R., de Oliveira, C. I., Santos-Muccillo, P., Bezerra, J. F., Teixeira, D. L. F., Riediger, I., Debur, M. C., Ribeiro-Rodrigues, R., Leite, A. B., do Santos, C. A., Gregianini, T. S., Fernandes, S. B., Bernardes, A. F. L., Cavalcanti, A. C., Miyajima, F., Sachhi, C., Mattos, T., da Costa, C. F., Delatorre, E., Wallau, G. L., Naveca, F. G., Bello, G., Siqueira, M. M.
10.1101/2021.03.12.434969 — Posted: 2021-03-13
The causal effect of serum vitamin D concentration on COVID-19 susceptibility, severity and hospitalization traits: a Mendelian randomization study
Cui, Z., Tian, Y.
10.1101/2021.03.08.21252901 — Posted: 2021-03-13
Engagement with daily testing instead of self-isolating in contacts of confirmed cases of SARS-CoV-2.
Martin, A. F., Denford, S., Love, N., Ready, D., Oliver, I., Amlot, R., Rubin, G. J., Yardley, L.
10.1101/2021.03.13.21253500 — Posted: 2021-03-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).